Duoneb and Sputum increased - a phase IV clinical study of FDA data

Summary:

Sputum increased is reported as a side effect among people who take Duoneb (albuterol sulfate; ipratropium bromide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Heparin, and have Bronchiectasis.

The phase IV clinical study analyzes which people have Sputum increased when taking Duoneb. It is created by eHealthMe based on reports of 8,008 people who have side effects when taking Duoneb from the FDA, and is updated regularly.

What is Duoneb?

Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.

What is Sputum increased?

Sputum increased is found to be associated with 428 drugs and 355 conditions by eHealthMe. Check the latest studies of Sputum increased.

On Jul, 13, 2026

8,008 people reported to have side effects when taking Duoneb.
Among them, 21 people (0.26%) have Sputum increased.

Among these 21 people:

How long have people been on Duoneb when they have Sputum increased? *

What is the gender of people who have Sputum increased when taking Duoneb? *

female: 25 %
male: 75 %

What is the age of people who have Sputum increased when taking Duoneb? *

What are other drugs people take besides Duoneb? *

What are other side effects people have besides Sputum increased? *

Dyspnea (difficult or laboured breathing): 19 people, 90.48%
Cough: 16 people, 76.19%
Weakness: 12 people, 57.14%
Chest Pain: 11 people, 52.38%
Headache (pain in head): 10 people, 47.62%
Urticaria (rash of round, red welts on the skin that itch intensely): 10 people, 47.62%
Itching: 10 people, 47.62%
Sputum Discolored: 8 people, 38.10%
Fever: 8 people, 38.10%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 33.33%

What are the existing conditions these people have? *

Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 10 people, 47.62%
Stress And Anxiety: 8 people, 38.10%
Cough: 8 people, 38.10%
Nausea (feeling of having an urge to vomit): 7 people, 33.33%
Wheezing (a high-pitched whistling sound made while you breath): 6 people, 28.57%
Faeces Hard: 6 people, 28.57%
Migraine Without Aura (headache without neurological problems): 6 people, 28.57%
Itching: 6 people, 28.57%
Impaired Gastric Emptying: 6 people, 28.57%
Headache (pain in head): 6 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take Duoneb and have Sputum increased?

- Check whether Sputum increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Duoneb:

Duoneb (8,093 reports)

Sputum increased treatments and more:

Sputum increased (3,380 reports)

How severe was Sputum increased and when was it recovered:

Sputum increased in Duoneb

Expand to all the drugs that have ingredients of albuterol sulfate; ipratropium bromide:

Sputum increased and drugs with ingredients of albuterol sulfate; ipratropium bromide (67 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sputum increased:

Sputum increased (428 drugs)

Browse all the conditions that are associated with Sputum increased:

Sputum increased (355 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide (the active ingredients of Duoneb) and Duoneb (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.